Evidence map›Paper›PMID 25973924›Full record

ArticlePloS one2015

Association of respiratory viruses with outcomes of severe childhood pneumonia in Botswana.

Matthew S Kelly, Marek Smieja, Kathy Luinstra, Kathleen E Wirth, David M Goldfarb, Andrew P Steenhoff, Tonya Arscott-Mills, Coleen K Cunningham, Sefelani Boiditswe, Warona Sethomo and 3 more

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Matthew S KellyBotswana-UPenn Partnership, Gaborone, Botswana; Global Health Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America; Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America.
Marek SmiejaDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Kathy LuinstraDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Kathleen E WirthDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
David M GoldfarbBotswana-UPenn Partnership, Gaborone, Botswana; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; University of Botswana School of Medicine, Gaborone, Botswana.
Andrew P SteenhoffBotswana-UPenn Partnership, Gaborone, Botswana; Global Health Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America; Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Tonya Arscott-MillsBotswana-UPenn Partnership, Gaborone, Botswana; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Coleen K CunninghamDivision of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America.
Sefelani BoiditsweBotswana-UPenn Partnership, Gaborone, Botswana.
Warona SethomoUniversity of Botswana School of Medicine, Gaborone, Botswana.
Samir S ShahDivisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
Rodney FinalleGlobal Health Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Kristen A FeemsterGlobal Health Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America; Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID S METZGER · 1999 to 2026
$78.6M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI GEORGIA Doris TOMARAS · 2005 to 2026
$50.5M
Institutional Training Grant in Pediatric Infectious DiseaseT32HD060558 · NICHD · DUKE UNIVERSITY · PI CUNNINGHAM, COLEEN K. · 2011 to 2015
$1.0M
Healthcare-associated respiratory infection in the pediatric ambulatory settingK08HS020939 · AHRQ · CHILDREN'S HOSP OF PHILADELPHIA · PI FEEMSTER, KRISTEN A · 2012 to 2016
$676k
AHRQ HHS K08 HS020939NIAID NIH HHS P30 AI045008NIAID NIH HHS P30-AI045008NIAID NIH HHS P30 AI064518NIAID NIH HHS P30-AI064518NICHD NIH HHS T32 HD060558
6 · The paper itself

Abstract

backgroundThe highest incidence of childhood acute lower respiratory tract infection (ALRI) is in low- and middle-income countries. Few studies examined whether detection of respiratory viruses predicts ALRI outcomes in these settings.

methodsWe conducted prospective cohort and case-control studies of children 1-23 months of age in Botswana. Cases met clinical criteria for pneumonia and were recruited within six hours of presentation to a referral hospital. Controls were children without pneumonia matched to cases by primary care clinic and date of enrollment. Nasopharyngeal specimens were tested for respiratory viruses using polymerase chain reaction. We compared detection rates of specific viruses in matched case-control pairs. We examined the effect of respiratory syncytial virus (RSV) and other respiratory viruses on pneumonia outcomes.

resultsBetween April 2012 and August 2014, we enrolled 310 cases, of which 133 had matched controls. Median ages of cases and controls were 6.1 and 6.4 months, respectively. One or more viruses were detected from 75% of cases and 34% of controls. RSV and human metapneumovirus were more frequent among cases than controls, but only enterovirus/rhinovirus was detected from asymptomatic controls. Compared with non-RSV viruses, RSV was associated with an increased risk of treatment failure at 48 hours [risk ratio (RR): 1.85; 95% confidence interval (CI): 1.20, 2.84], more days of respiratory support [mean difference (MD): 1.26 days; 95% CI: 0.30, 2.22 days], and longer duration of hospitalization [MD: 1.35 days; 95% CI: 0.20, 2.50 days], but lower in-hospital mortality [RR: 0.09; 95% CI: 0.01, 0.80] in children with pneumonia.

conclusionsRespiratory viruses were detected from most children hospitalized with ALRI in Botswana, but only RSV and human metapneumovirus were more frequent than among children without ALRI. Detection of RSV from children with ALRI predicted a protracted illness course but lower mortality compared with non-RSV viruses.

Indexed as

BotswanaCase-Control StudiesCohort StudiesEnterovirusFemaleHumansInfantMaleMetapneumovirusMultiplex Polymerase Chain ReactionPneumoniaProspective StudiesReferral and ConsultationRespiratory Syncytial VirusesRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsRNA, Viral

Identifiers

PMID25973924
PMCPMC4431806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.